BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 20515650)

  • 1. An improved method for cell-to-cell transmission of infectious prion.
    Tanaka M; Hara H; Nishina H; Hanada K; Hagiwara K; Maehama T
    Biochem Biophys Res Commun; 2010 Jul; 397(3):505-8. PubMed ID: 20515650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The brain to gut pathway: a possible route of prion transmission.
    Lawson VA; Furness JB; Klemm HM; Pontell L; Chan E; Hill AF; Chiocchetti R
    Gut; 2010 Dec; 59(12):1643-51. PubMed ID: 21071583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of cell lines propagating infectious prions and the isolation and characterization of cell-derived exosomes.
    Vella LJ; Hill AF
    Methods Mol Biol; 2008; 459():69-82. PubMed ID: 18576148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion proteins: a biological role beyond prion diseases.
    Hu W; Rosenberg RN; Stüve O
    Acta Neurol Scand; 2007 Aug; 116(2):75-82. PubMed ID: 17661791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of PrP(Sc) transmission from immune cells to neuronal cells.
    Tanaka Y; Sadaike T; Inoshima Y; Ishiguro N
    Cell Immunol; 2012 Oct; 279(2):145-50. PubMed ID: 23246505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of disease-associated prion protein to plasminogen.
    Fischer MB; Roeckl C; Parizek P; Schwarz HP; Aguzzi A
    Nature; 2000 Nov; 408(6811):479-83. PubMed ID: 11100730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prion inactivation by the Maillard reaction.
    Suyama K; Yoshioka M; Akagawa M; Murayama Y; Horii H; Takata M; Yokoyama T; Mohri S
    Biochem Biophys Res Commun; 2007 Apr; 356(1):245-8. PubMed ID: 17336934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of cell responses to PrP(Sc) in prolonged cell culture and its effect on transmission of PrP(Sc) to neural cells.
    Elhelaly AE; Inoshima Y; Ishiguro N
    Arch Virol; 2013 Mar; 158(3):651-8. PubMed ID: 23160705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lithium induces clearance of protease resistant prion protein in prion-infected cells by induction of autophagy.
    Heiseke A; Aguib Y; Riemer C; Baier M; Schätzl HM
    J Neurochem; 2009 Apr; 109(1):25-34. PubMed ID: 19183256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of genuine prion infectivity by serial PMCA.
    Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
    Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroendocrine cultured cells counteract persistent prion infection by down-regulation of PrPc.
    Aguib Y; Gilch S; Krammer C; Ertmer A; Groschup MH; Schätzl HM
    Mol Cell Neurosci; 2008 May; 38(1):98-109. PubMed ID: 18387818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced neuroprotection independently from PrPSc accumulation in a mouse model for prion disease treated with simvastatin.
    Haviv Y; Avrahami D; Ovadia H; Ben-Hur T; Gabizon R; Sharon R
    Arch Neurol; 2008 Jun; 65(6):762-75. PubMed ID: 18541796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
    White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
    Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategies for eliminating PrP(c) as substrate for prion conversion and for enhancing PrP(Sc) degradation.
    Gilch S; Nunziante M; Ertmer A; Schätzl HM
    Vet Microbiol; 2007 Aug; 123(4):377-86. PubMed ID: 17493775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-induced alterations of membrane lipids affect the incorporation of PrP Sc into cells.
    Avrahami D; Dayan-Amouyal Y; Tal S; Mincberg M; Davis C; Abramsky O; Gabizon R
    J Neurosci Res; 2008 Sep; 86(12):2753-62. PubMed ID: 18478553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
    Piening N; Weber P; Giese A; Kretzschmar H
    Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of oligomeric prion-protein aggregates in a mouse model of prion disease.
    Sasaki K; Minaki H; Iwaki T
    J Pathol; 2009 Sep; 219(1):123-30. PubMed ID: 19479969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
    Uppington KM; Brown DR
    J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scrapie prion protein accumulation by scrapie-infected neuroblastoma cells abrogated by exposure to a prion protein antibody.
    Enari M; Flechsig E; Weissmann C
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9295-9. PubMed ID: 11470893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.